Michael T.H. Wong
Mental Health Research Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael T.H. Wong.
Psychiatry Research-neuroimaging | 2003
David L. Copolov; Marc L. Seal; Paul Maruff; Recep Ulusoy; Michael T.H. Wong; Henri Tochon-Danguy; Gary F. Egan
A [H(2)(15)O] PET correlation analysis technique was employed to correlate brain activations associated with self-reports of auditory hallucinations in hallucinating patients (n=8) and perception of transient, random human speech in non-hallucinating (n=7) patients and normal control subjects (n=8). Perception of externally generated human speech amongst the non-hallucinating and normal control participants was associated with a consistent pattern of extensive bilateral auditory cortex activation (Brodmann areas 40/41/42/22). Hallucinating participants demonstrated a network of cortical activations including bilateral auditory cortex, left limbic regions, right medial frontal and right prefrontal regions. The observed pattern of activation is consistent with models of auditory hallucinations as mis-remembered episodic memories of speech.
Psychiatry Research-neuroimaging | 2012
Andreas Bechdolf; Stephen J. Wood; Barnaby Nelson; Dennis Velakoulis; Murat Yücel; Tsutomu Takahashi; Alison R. Yung; Michael Berk; Michael T.H. Wong; Christos Pantelis; Patrick D. McGorry
There are now numerous reports of neuroanatomical abnormalities in people with bipolar disorder. However, it remains unclear whether those abnormalities predate the onset of the illness. In this cross-sectional magnetic resonance imaging study, we assessed 11 young people clinically at ultra-high risk of development of psychosis (UHR), who all developed bipolar I or II disorder by follow-up (median time to onset 328 days - UHR-BP), 11 matched UHR participants, who had no psychiatric diagnosis after at least 12 months of follow-up (UHR-Well) and 11 matched healthy controls (HC). Our main outcome measures were amygdala, hippocampus, insula, lateral ventricular and whole brain volumes. Amygdala and insula volume reductions were more pronounced in the UHR-BP than in the UHR-Well and HC group. Lateral ventricle, whole-brain and hippocampal volumes did not differ between groups. If these findings are confirmed, they suggest that imaging investigations could help to distinguish people who will subsequently develop bipolar disorder from those who will not, at least in symptomatically enriched samples.
Progress in Neuro-psychopharmacology & Biological Psychiatry | 2009
Tsutomu Takahashi; Stephen J. Wood; Bridget Soulsby; Ryoichiro Tanino; Michael T.H. Wong; Patrick D. McGorry; Michio Suzuki; Dennis Velakoulis; Christos Pantelis
Volume reductions of the insular cortex have been described in schizophrenia, but it remains unclear whether other psychotic disorders such as affective psychosis also exhibit insular cortex abnormalities. In this study, we used magnetic resonance imaging to investigate the gray matter volume of the anterior (short) and posterior (long) insular cortices in 162 first-episode patients with various psychotic disorders (46 schizophrenia, 57 schizophreniform disorder, 34 affective psychosis, and 25 other psychoses) and 62 age- and gender-matched healthy comparison subjects. Patients with schizophrenia showed bilateral volume reduction of the anterior and posterior insular cortices compared with controls, but the remaining first-episode psychosis subgroups had normal insular volumes. The volumes of these insular subregions were significantly smaller in schizophrenia patients than in patients with schizophreniform disorder or affective psychoses. There was no association between the insular cortex volume and daily dosage or type of antipsychotic medication in any patient group. These findings suggest that the widespread volume reduction of the insular cortex is specific to established schizophrenia, implicating its role in the neurobiology of clinical characteristics associated with schizophrenia.
British Journal of Psychiatry | 2017
Michael Berk; Rothanthi Daglas; Orwa Dandash; Murat Yücel; Lisa Henry; Kt Hallam; Craig A. Macneil; Melissa K. Hasty; Christos Pantelis; Brendan P. Murphy; Linda Kader; Saji Damodaran; Michael T.H. Wong; Philippe Conus; Aswin Ratheesh; Patrick D. McGorry; Sue Cotton
BackgroundLithium and quetiapine are considered standard maintenance agents for bipolar disorder yet it is unclear how their efficacy compares with each other.AimsTo investigate the differential effect of lithium and quetiapine on symptoms of depression, mania, general functioning, global illness severity and quality of life in patients with recently stabilised first-episode mania.MethodMaintenance trial of patients with first-episode mania stabilised on a combination of lithium and quetiapine, subsequently randomised to lithium or quetiapine monotherapy (up to 800 mg/day) and followed up for 1 year. (Trial registration: Australian and New Zealand Clinical Trials Registry - ACTRN12607000639426.)ResultsIn total, 61 individuals were randomised. Within mixed-model repeated measures analyses, significant omnibus treatment × visit interactions were observed for measures of overall psychopathology, psychotic symptoms and functioning. Planned and post hoc comparisons further demonstrated the superiority of lithium treatment over quetiapine.ConclusionsIn people with first-episode mania treated with a combination of lithium and quetiapine, continuation treatment with lithium rather than quetiapine is superior in terms of mean levels of symptoms during a 1-year evolution.
Acta Neuropsychiatrica | 2006
Murat Yücel; Dan I. Lubman; Dennis Velakoulis; Michael T.H. Wong; Stephen J. Wood; Anita Condello; Warrick J. Brewer; Christos Pantelis
Background: Previous studies on substance-dependent populations have shown that age of first use and duration of use are associated with alterations in regional brain volumes. However, it is not clear whether such alterations are factors that predispose young people to use, and so are also present in recreational users, or are a consequence of chronic exposure to substances and/or comorbid psychopathology. Objective: To investigate relationships between key brain structures and parameters of alcohol and cannabis use, in otherwise healthy male recreational users. Method: High-resolution magnetic resonance imaging was used to measure hippocampal, amygdala, whole-brain and intracranial cavity (ICC) volumes in 22 young men with a history of both alcohol and cannabis use. Results: Linear regression analyses with hippocampal, amygdala and whole-brain volumes as the dependent variables and age and ICC as covariates were performed. Findings showed that use of cannabis and alcohol at an earlier age were independently predictive of larger amygdala volumes, whereas longer duration of cannabis use was predictive of smaller hippocampal volumes. Conclusions: Our findings offer preliminary support for a relationship between patterns of substance use and regional brain volumes in recreational users. It is speculative, but possible that this relationship is an evidence of a neurobiological vulnerability to drug-taking behaviour.
The International Journal of Leadership in Public Services | 2011
Michael T.H. Wong
Purpose – This paper seeks to provide a view on the relevance of spirituality to leadership at various levels and areas of the practice of psychiatry.Design/methodology/approach – The paper provides a background and discussion on the relevance of spirituality to leadership at various levels and areas of the practice of psychiatry, with particular reference to Australia.Findings – The author argues that spirituality is relevant to leadership in educating medical undergraduates, training professional psychiatrists, conducting clinical research, delivering mental health services and removing public stigma of mental health problems.Originality/value – The author provides the unique perspective of a medical specialist practising in different areas and levels of psychiatry on spirituality and leadership.
Archives of General Psychiatry | 2006
Dennis Velakoulis; Stephen J. Wood; Michael T.H. Wong; Patrick D. McGorry; Alison R. Yung; Lisa J. Phillips; De Smith; Warrick J. Brewer; Tina Proffitt; Patricia Desmond; Christos Pantelis
Australian and New Zealand Journal of Psychiatry | 2005
Michael T.H. Wong; Christine Tye
Biological Psychiatry | 2000
David L. Copolov; Marc L. Seal; Paul Maruff; M. Waite; Michael T.H. Wong; Recep Ulusoy; Gary F. Egan
Archive | 2011
Jky Chan; Gh Xing; Y Xu; Sc Wu; Ckc Wong; Ckm Leung; Michael T.H. Wong